Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN PHARMS INC

  • FDA Approval
  • May 31, 2024, 08:56 UTC
  • 43
  • 0 comments

FDA approve SIMVASTATIN

Comment Full text

HOSPIRA

  • FDA Approval
  • May 31, 2024, 08:56 UTC
  • 43
  • 0 comments

FDA approve INDOMETHACIN SODIUM

Comment Full text

L PERRIGO CO

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 39
  • 0 comments

FDA approve MICONAZOLE NITRATE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 41
  • 0 comments

FDA approve AMOXAPINE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 38
  • 0 comments

FDA approve AMOXAPINE

Comment Full text

ALEMBIC

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 39
  • 0 comments

FDA approve SACUBITRIL; VALSARTAN

Comment Full text

CONTRACT PHARMACAL

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 37
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text

LAURUS

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 38
  • 0 comments

FDA approve SACUBITRIL; VALSARTAN

Comment Full text

ALLERGAN

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 51
  • 0 comments

FDA approve OXYBUTYNIN

Comment Full text

HIKMA

  • FDA Approval
  • May 30, 2024, 08:45 UTC
  • 36
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text
  • Previous
  • 441
  • 442
  • 443
  • 444
  • 445
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3907)
  • SEC News(228375)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140741)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin